ICDcodes.org
FY2027

F16.20Hallucinogen dependence, uncomplicated

BillableCC

Is F16.20 billable?

Yes — F16.20 is billable for FY2027. F16.20 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. F16.20 may be submitted for encounters from October 1, 2026 through September 30, 2027.

F16.20 at a glance

CodeF16.20
DescriptionHallucinogen dependence, uncomplicated
BillableYes
Code setICD-10-CM FY2027
Valid for encountersOctober 1, 2026 – September 30, 2027

Which MS-DRGs does F16.20 group to?

F16.20 sits in MDC 20 and helps define the logic of 4 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.

  • 894Alcohol, Drug Abuse or Dependence, Left AMAmedical
  • 895Alcohol, Drug Abuse or Dependence with Rehabilitation Therapymedical
  • 896Alcohol, Drug Abuse or Dependence without Rehabilitation Therapy with MCCmedical
  • 897Alcohol, Drug Abuse or Dependence without Rehabilitation Therapy without MCCmedical

As a secondary diagnosis, F16.20 is a complication or comorbidity (CC), which can move a stay into a higher-paying DRG.

How is F16.20 listed in the Alphabetic Index?

These are the routes through the Alphabetic Index that lead to F16.20. They show the wording a clinician may have documented, which often differs from the Tabular description.

  • LSD reactionwith dependence (acute) (without dependence)
  • Dependencedrug NEChallucinogen (on) (syndrome)
  • Disorderhallucinogen usemoderate or severe (of)
  • Disorderphencyclidine usemoderate or severe (of)

Inclusion terms

Alternative wording in documentation that is classified to F16.20.

  • Other hallucinogen use disorder, moderate
  • Other hallucinogen use disorder, severe
  • Phencyclidine use disorder, moderate
  • Phencyclidine use disorder, severe

Excludes1 — never code together — inherited from F16.2

The conditions below can never be reported together with F16.20 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • hallucinogen abuse (F16.1-)
  • hallucinogen use, unspecified (F16.9-)

Excludes2 — not included here — inherited from Chapter 5

The conditions below are not part of F16.20, but a patient may have both at the same time. When documentation supports it, F16.20 and the excluded code may both be reported.

  • symptoms, signs and abnormal clinical laboratory findings, not elsewhere classified (R00-R99)

How long has F16.20 existed?

F16.20 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.

Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.

Which conditions are coded to F16.20?

What other codes are in the F16.2 family? (6)